Select Page
Moderna Moves into Phase 2 of Covid Vaccine

Moderna Moves into Phase 2 of Covid Vaccine

In their business update, Moderna announced they received FDA clearance to move into Phase 2 of their study for the COVID-19 vaccine. In their press release, they also reported additional funding from Biomedical Advanced Research and Development Authority (BARDA) as...
Exploring the World of Vaccinations

Exploring the World of Vaccinations

Explore the world of vaccinations with Professor K in understanding what they are, how they work, and the challenges faced in development and implementation, especially for COVID-19.
FDA Amends Policy for Covid Tests

FDA Amends Policy for Covid Tests

The FDA announced that it would strengthen its oversight for companies marketing the Covid serology tests. After questions came to light in regards to the accuracy of some of the testing kits, the FDA is now requiring commercial manufacturers to submit an emergency...
FDA Grants EUA for Covid Treatment Remdesivir from Gilead

FDA Grants EUA for Covid Treatment Remdesivir from Gilead

The FDA announced today (5/1) that it would grant EUA for Gilead for their antiviral drug remdesivir for treatment in early response to suspected or confirmed patients with Covid. This authorization will allow the distribution of the drug all over the US, as well as...
EU Gives Five New Guidances for Medical Devices

EU Gives Five New Guidances for Medical Devices

The European Commission’s Medical Device Coordination Group (MDCG) posted five new guidances on Friday (4/24) for medical devices in light of COVID-19. These guidances are used when demonstrating equivalence to existing devices,...
EU Unanimously Votes to Delay EU MDR by 1 Year

EU Unanimously Votes to Delay EU MDR by 1 Year

In a unanimous decision on Wednesday (4/22), the European Union has decided to push back the amendment to the EU MDR by one year amidst the COVID-19 pandemic. This extra time will allow more time to ensure the functionality and design of the new system, while also...